Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. Oct 24, 2022; 13(10): 779-788
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.779
Table 1 Clinicodemographics and histologic features in 526 patients with colorectal adenocarcinoma (PanCancer Atlas)
Feature
Level
Number
MSS number
Age (yr), mean ± SD65.8 ± 13.065.4 ± 12.7
GenderFemale 252 (47.9%)218 (47.1%)
Male272 (51.7%)243 (52.5%)
Unknown2 (0.4%)2 (0.4%)
Histopathologic differentiationWell19 (3.6%)18 (3.9%)
Moderate381 (72.4%)351 (75.8%)
Poor114 (21.7%)83 (17.9%)
Unknown12 (2.3%)11 (2.4%)
Tumor location Left254 (48.3%)248 (53.6%)
Right197 (37.5%)149 (32.2%)
Left and right3 (0.6%)3 (6.5%)
Unknown72 (13.7%)63 (13.6%)
Tumor staging (pT)T118 (3.4%)17 (3.7%)
T294 (17.9%)83 (17.9%)
T3355 (67.5%)310 (67.0%)
T457 (10.8%)52 (11.2%)
TX2 (0.4%)2 (0.4%)
Nodal staging (pN)N0305 (58.0%)255 (55.1%)
N1128 (24.3%)120 (25.9%)
N290 (17.1%)85 (18.4%)
NX3 (0.6%)3 (6.5%)
Metastasis (pM)M0388 (73.8%)338 (73.0%)
M168 (12.9%)66 (14.3%)
MX70 (13.3%)59 (12.7%)
Lymphovascular invasionPresent178 (33.8%)157 (33.9%)
Absent230 (43.7%)202 (43.6%)
Unknown118 (22.4%)104 (22.5%)
EthnicityCaucasian273 (51.9%)236 (51.0%)
African-American60 (11.4%)51 (11.0%)
Asian12 (2.3%)11 (2.4%)
Unknown181 (34.4%)165 (35.6%)
SubtypeCIN328 (62.4%)
MSI63 (12.0%)
GS58 (11.0%)
POLE10 (1.9%)
Unknown57 (10.8%)
Total526463